Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH

CONTEXT: Somapacitan is a long-acting GH derivative for treatment of GH deficiency (GHD). OBJECTIVE: Evaluate the efficacy and tolerability of somapacitan in children with GHD after 2 years of treatment and after the switch from daily GH. DESIGN: A randomized, multinational, open-labelled, controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Bradley S, Blair, Joanne C, Rasmussen, Michael Højby, Maniatis, Aristides, Mori, Jun, Böttcher, Volker, Kim, Ho-Seong, Bang, Rikke Beck, Polak, Michel, Horikawa, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655534/
https://www.ncbi.nlm.nih.gov/pubmed/37406251
http://dx.doi.org/10.1210/clinem/dgad394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655534/
https://www.ncbi.nlm.nih.gov/pubmed/37406251
http://dx.doi.org/10.1210/clinem/dgad394

Ejemplares similares